A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
about
Glioblastoma cells express functional cell membrane receptors activated by daily used medical drugs.Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancerAdministration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.Neuropeptides of the VIP family inhibit glioblastoma cell invasion.
P2860
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@en
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@nl
type
label
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@en
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@nl
prefLabel
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@en
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@nl
P2093
P356
P1476
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.
@en
P2093
D Brenneman
P2888
P304
P356
10.1385/JMN:17:3:331
P577
2001-12-01T00:00:00Z
P6179
1030107258